Ribomic Inc. (TYO:4591)
Japan · Delayed Price · Currency is JPY 77.00
-2.00 (-2.53%)
Sep 16, 2026, 3:30 PM JST
Ribomic Market Cap
Ribomic has a market cap or net worth of 4.47 billion as of September 15, 2026. Its market cap has increased by 3.29% in one year.
Market Cap
4.47B
Enterprise Value
1.69B
Revenue
7.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
77.00
ChartMarket Cap Chart
Since September 25, 2014, Ribomic's market cap has decreased from 22.97B to 4.47B, a decrease of -80.55%. That is a compound annual growth rate of -12.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 4.47B | 8.45% |
| Dec 30, 2025 | 4.12B | 20.26% |
| Dec 30, 2024 | 3.43B | -11.13% |
| Dec 29, 2023 | 3.85B | -41.00% |
| Dec 30, 2022 | 6.53B | -43.16% |
| Dec 30, 2021 | 11.49B | 13.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 6.05B |
| Noile-Immune Biotech | 6.03B |
| PRISM BioLab Co.,LTD | 5.99B |
| Soiken Holdings | 5.57B |
| TMS Co., Ltd. | 5.39B |
| Chordia Therapeutics | 5.33B |
| D. Western Therapeutics Institute | 5.01B |
| Transgenic Group | 4.33B |